Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Nov 01, 2021 | Nov 03, 2021 | Gerberding Julie L. EVP Chief Patient Officer | Sell | Merck & Co., Inc. | MRK | $87.91 | $8M | -71.08% |
Jul 17, 2020 | Jul 20, 2020 | Gerberding Julie L. EVP Strat Comm GI Pub Policy | Sell | Merck & Co., Inc. | MRK | $80 | $3M | -57.72% |
Jan 13, 2020 | Jan 15, 2020 | Gerberding Julie L. EVP Strat Comm GI Pub Policy | Sell | Merck & Co., Inc. | MRK | $89.34 | $9M | -73.38% |
Aug 22, 2019 | Aug 23, 2019 | Gerberding Julie L. Dir | Sell | Cerner Corp | CERN | $71.82 | $569,389 | -49.38% |
Nov 07, 2018 | Nov 08, 2018 | Gerberding Julie L. EVP Strat Comm Gl Pub Policy | Sell | Merck & Co., Inc. | MRK | $75.14 | $3M | -43.91% |
May 15, 2018 | May 16, 2018 | Gerberding Julie L. EVP Strat Comm Gl Pub Policy | Sell | Merck & Co., Inc. | MRK | $59.66 | $594,963 | -17.91% |
Nov 07, 2016 | Nov 08, 2016 | Gerberding Julie L. EVP Strat Comm Gl Pub Policy | Sell | Merck & Co., Inc. | MRK | $60.02 | $5M | -68.62% |
May 08, 2015 | May 11, 2015 | Gerberding Julie L. EVP Strat Comm Gl Pub Policy | Sell | Merck & Co., Inc. | MRK | $60.99 | $2M | -54.54% |